Mike Milburn, Ph.D.

Chief Scientific Officer

Dr. Milburn has served as Chief Scientific Officer at Metabolon since 2005 and is responsible for our metabolomics technology development, laboratory operations, informatics, and data science. Before joining Metabolon, he was senior vice president of research and corporate development at Sirtris Pharmaceuticals, where he led the preclinical/clinical development of drugs in metabolic disease and neurodegeneration. Prior to Sirtris, he held various senior-level positions at Plexxikon, Glaxo and GlaxoWellcome. Dr. Milburn received his Ph.D. in biophysical chemistry from the University of California, Berkeley and was a post-doctoral research fellow at Harvard Medical School.